Role of phosphate depletion and high dialysate calcium in controlling dialytic renal osteodystrophy.
D000536:Aluminum Hydroxide / Q000627:therapeutic use; D001693:Biological Transport, Active; D002118:Calcium / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D002254:Carbonates / Q000627:therapeutic use; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D006934:Hypercalcemia / Q000601:surgery; D007676:Kidney Failure, Chronic / Q000628:therapy; D010280:Parathyroid Glands / Q000502:physiology / Q000601:surgery; D010281:Parathyroid Hormone / Q000097:blood / Q000502:physiology; D010710:Phosphates / Q000097:blood / Q000378:metabolism*; D006435:Renal Dialysis / Q000009:adverse effects*; D014807:Vitamin D / Q000378:metabolism
D002254:Carbonates; D010281:Parathyroid Hormone; D010710:Phosphates; D014807:Vitamin D; D000536:Aluminum Hydroxide; D002118:Calcium